IMBCAMS reveals Phase 2 clinical trial of COVID-19 vaccine in China

Date: 2020-06-22   Author: Saipriya Iyer  Category: #news

IMBCAMS reveals Phase 2 clinical trial of COVID-19 vaccine in China

The IMB (Institute of Medical Biology) at the CAMS (Chinese Academy of Medical Sciences) has recently stated that Chinese researchers have started the Phase 2 COVID-19 vaccine trial. The 2nd phase of this potential coronavirus vaccine has been commenced to examine its safety and effectiveness.

There are nearly a dozen COVID-19 vaccines that are currently under the human trial phase across the globe. The WHO (World Health Organization) has informed about the accelerating cases and impacts of the coronavirus pandemic, which has reshaped the global order and placed people at higher risks. In the wake of this pandemic, however, no vaccines have passed the late-stage, large scale Phase 3 clinical trial, the crucial step needed prior to getting the regulatory approval for selling the vaccine globally.

Among other researchers, the IMBCAMS has recently begun the Phase 2 human trial for the experimental study. The vaccine that is currently under trial is among the six vaccines that are being developed by the Chinese researchers against the COVID-19 vaccine.

The institute has reportedly stated that nearly 200 participants were included in the 1st phase of the vaccine trial that was conducted in May. This Phase 2 trial will target to emphasize on the immune responses among healthy patients while determining the dose of the vaccine. It also stated its aim to adopt a plant for producing the COVID-19 vaccine in 2020, which in turn, will help in preparing the future vaccine supplies in China.

According to Gao Fu, Director of China CDC (Chinese Center for Disease Control & Prevention), some groups of high-risk special needs patients can use the experimental vaccine under urgent circumstances by 2020 end.

The pandemic, which was discovered for the 1st time in late 2019, has impacted nearly 8.81 million and claimed the lives of over 460,000 people across the globe.

Source credit:

https://www.thehindubusinessline.com/news/world/china-begins-phase-2-of-the-clinical-trial-for-potential-covid-19-vaccine/article31882148.ece



About Author


Saipriya Iyer linkdin-boxtwitter

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

Post Recommendents

Data Center Power Management Market Expected to Witness High Growth over the Forecast Period 2021 - 2026

Author: Ashwin Naphade

The ' Data Center Power Management market' study now available with Market Study Report, LLC, delivers a concise outlook of the powerful trends driving market growth. This report also includes valuable information pertaining to market share, marke...


Business Value Dashboard Market Outlook | Development Factors, Latest Opportunities and Forecast 2026

Author: Ashwin Naphade

The ' Business Value Dashboard market' study recently added by Market Study Report, LLC, offers an in-depth analysis of the current market trends influencing this business vertical. The study also includes market valuation, market size, revenue fo...


Global Cloud Based Backup Services Market - Detailed Analysis of Current Industry Figures with Forecasts Growth By 2026

Author: Ashwin Naphade

Market Study Report, LLC, provides a research on the ' Cloud Based Backup Services market' which offers a concise summary pertaining to industry valuation, SWOT Analysis, market size, revenue estimation and geographical outlook of the business ver...